Financhill
Back

Kymera Therapeutics 10K Form

Sell
41

KYMR
Kymera Therapeutics

Last Price:
31.32
Seasonality Move:
37.37%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive KYMR News And Ratings

See the #1 stock for the next 7 days that we like better than KYMR

KYMR Financial Statistics

Sales & Book Value

Annual Sales: $78.59M
Cash Flow: $-46.99M
Price / Cash Flow: 0
Annual Sales: $11.59
Price / Book: 2.69

Profitability

EPS (TTM): -2.51000
Net Income (TTM): $-154.59M
Gross Margin: --
Return on Equity: -32.22%
Return on Assets: -24.21%

Kymera Therapeutics Earnings Forecast

Key Kymera Therapeutics Financial Ratios

  • The Research & Development expenses have been 240.59% of Revenue.
  • The Interest Expense is -0.13% of Operating Income.
  • The Net Earning history of KYMR is -186.99% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Kymera Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: KYMR
Website: kymeratx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 9.57
Quick Ratio: 9.31

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

KYMR Technical Analysis vs Fundamental Analysis

Sell
41
Kymera Therapeutics (KYMR) is a Sell

Is Kymera Therapeutics a Buy or a Sell?